(Q52763791)

English

Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study.

scientific article published on 29 November 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

Correlation of biologically effective dose and the tumor control in Stage I (<5 cm) non-small cell lung cancer with stereotactic ablative radiotherapy: a single institutional cohort study. (English)

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

author name string

Wan Jeon

1

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

Sung-Ja Ahn

2

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

Young-Chul Kim

3

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

In-Jae Oh

4

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

Chul-Kyu Park

5

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

Jae-Uk Jeong

6

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

Mee Sun Yoon

7

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

Ju-Young Song

8

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

Taek-Keun Nam

9

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

Woong-Ki Chung

10

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

publication date

29 November 2017

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

Japanese Journal of Clinical Oncology

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

48

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

144-152

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

2

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

Cancer Statistics, 2017.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Stereotactic body radiotherapy for early stage lung cancer: History and updated role

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Stereotactic body radiation therapy for inoperable early stage lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Long-term survival after video-assisted thoracic surgery lobectomy for primary lung cancer.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYX172

21 January 2018

Identifiers

10.1093/JJCO/HYX172

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

1 reference

Europe PubMed Central

7 May 2018

http://europepmc.org/abstract/MED/29194510

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52763791&oldid=842830297"